- In January 2021, Trevena, Inc. had announced the launch of opiod based medicine named Olinvyk (oliceridine) for the treatment of acute pain in adults. Olinvyk (oliceridine) was approved by FDA in August, 2020. OLINVYK contains oliceridine, an opioid-like Schedule II restricted narcotic with a significant potential for abuse
